Delivery Order SPE2DB20D1110-SPE2DB24FJ68Q

Award Date 10/19/23
Potential Completion Date 10/20/23
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) to provide Methylphenidate ER 18 mg tablets. The Firm Fixed Price Delivery Order, valued at $1,819.33, has an ultimate completion date of November 25, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,465.50 firm fixed-price delivery order is for the supply of 4,566,667,863 units of Methylphenidate ER 54 MG tablets. The contract has a ceiling value of $1,465.50 and an ultimate completion date of December 11, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Methylphenidate ER 27 mg tablets. The $3,577.84 firm fixed-price contract has a completion date of January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,319.97 firm fixed-price delivery order is for the supply of 4,567,193,190 units of Methylphenidate ER 18 mg tablets. The contract has an ultimate completion date of February 6, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,098.70 Firm Fixed Price delivery order is for the supply of 4,565,744,291 tablets of Methylphenidate ER 36 mg. The contract has an ultimate completion date of September 10, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,567,618,148 units of Methylphenidate ER 18 mg tablets. The $1,328.57 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has a period of performance through March 19, 2025 and was not set aside for any specific business type. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,370,660 units of methylphenidate ER 18 mg tablets. The firm-fixed-price delivery order, valued at $5,038.82, has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
This is a federal delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,335.40 firm fixed price contract is for the supply of Methylphenidate ER 36 mg tablets, with an ultimate completion date of August 16, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,369.51 Firm Fixed Price Delivery Order contract is for the supply of 4567303585 - Methylphenidate ER 36 mg Tablets in 100-count packages. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,664.29, is a delivery order for 4566472184 - Methylphenidate ER 54 mg tablets. The award has an ultimate completion date of November 19, 2024 and uses a firm fixed price pricing type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB24FJ68Q
    Delivery Order

This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide Methylphenidate ER 54 mg tablets. The Firm Fixed Price Delivery Order contract, valued at $1,057.57, has an ultimate completion date of October 20, 2023. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This contract does not have a set-aside designation, indicating open competition.

Generated 5/12/25, 10:38 AM